These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38312039)

  • 1. Cognitive and mental health trajectories of COVID-19: Role of hospitalisation and long-COVID symptoms.
    Vakani K; Ratto M; Sandford-James A; Antonova E; Kumari V
    Eur Psychiatry; 2024 Feb; 67(1):e17. PubMed ID: 38312039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and cognitive function: Evidence for increased processing speed variability in COVID-19 survivors and multifaceted impairment with long-COVID symptoms.
    Vakani K; Ratto M; Sandford-James A; Antonova E; Kumari V
    Eur Psychiatry; 2023 May; 66(1):e43. PubMed ID: 37170616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emotional, mental health and physical symptom experience of patients hospitalized with COVID-19 up to 3 months post-hospitalization: A longitudinal study.
    Tracy MF; Hagstrom S; Mathiason M; Wente S; Lindquist R
    J Clin Nurs; 2024 Feb; 33(2):591-605. PubMed ID: 37698148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairments among patients in a long-COVID clinic: Prevalence, pattern and relation to illness severity, work function and quality of life.
    Miskowiak KW; Pedersen JK; Gunnarsson DV; Roikjer TK; Podlekareva D; Hansen H; Dall CH; Johnsen S
    J Affect Disord; 2023 Mar; 324():162-169. PubMed ID: 36586593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive function and brain structure in COVID-19 survivors: The role of persistent symptoms.
    Vakani K; Norbury R; Vanova M; Ratto M; Parton A; Antonova E; Kumari V
    Behav Brain Res; 2025 Jan; 476():115283. PubMed ID: 39368712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study.
    Zhang H; Huang C; Gu X; Wang Y; Li X; Liu M; Wang Q; Xu J; Wang Y; Dai H; Zhang D; Cao B
    Lancet Respir Med; 2024 Jan; 12(1):55-66. PubMed ID: 38000376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalisation and surgery: are there hidden cognitive consequences? Evidence from The Irish Longitudinal study on Ageing (TILDA).
    O' Brien H; O' Leary N; Scarlett S; O' Hare C; Kenny RA
    Age Ageing; 2018 May; 47(3):408-415. PubMed ID: 29546387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Fatigue in Long COVID: Web-Based Quantitative Follow-up Study in Members of Online Long COVID Support Groups.
    Van Herck M; Goërtz YMJ; Houben-Wilke S; Machado FVC; Meys R; Delbressine JM; Vaes AW; Burtin C; Posthuma R; Franssen FME; Hajian B; Vijlbrief H; Spies Y; van 't Hul AJ; Janssen DJA; Spruit MA
    J Med Internet Res; 2021 Sep; 23(9):e30274. PubMed ID: 34494964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disentangling the cognitive, physical, and mental health sequelae of COVID-19.
    Wild CJ; Norton L; Menon DK; Ripsman DA; Swartz RH; Owen AM
    Cell Rep Med; 2022 Oct; 3(10):100750. PubMed ID: 36103880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-year quality of life and health-outcomes in patients hospitalised with COVID-19: a longitudinal cohort study.
    O'Brien K; Townsend L; Dowds J; Bannan C; Nadarajan P; Kent B; Murphy N; Sheill G; Martin-Loeches I; Guinan E
    Respir Res; 2022 May; 23(1):115. PubMed ID: 35509060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Impacts of a Four-Week Neuro-Meditation Program on Cognitive Function in Post-Acute Sequelae of COVID-19 Patients: A Randomized Controlled Trial.
    Hausswirth C; Schmit C; Rougier Y; Coste A
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment.
    Treanor CJ; McMenamin UC; O'Neill RF; Cardwell CR; Clarke MJ; Cantwell M; Donnelly M
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011325. PubMed ID: 27529826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study.
    Magnúsdóttir I; Lovik A; Unnarsdóttir AB; McCartney D; Ask H; Kõiv K; Christoffersen LAN; Johnson SU; Hauksdóttir A; Fawns-Ritchie C; Helenius D; González-Hijón J; Lu L; Ebrahimi OV; Hoffart A; Porteous DJ; Fang F; Jakobsdóttir J; Lehto K; Andreassen OA; Pedersen OBV; Aspelund T; Valdimarsdóttir UA;
    Lancet Public Health; 2022 May; 7(5):e406-e416. PubMed ID: 35298894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study.
    Dennis A; Cuthbertson DJ; Wootton D; Crooks M; Gabbay M; Eichert N; Mouchti S; Pansini M; Roca-Fernandez A; Thomaides-Brears H; Kelly M; Robson M; Hishmeh L; Attree E; Heightman M; Banerjee R; Banerjee A
    J R Soc Med; 2023 Mar; 116(3):97-112. PubMed ID: 36787802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical and cognitive impairments in people suffering from long COVID: protocol for a longitudinal population-based cohort study.
    Zahouani I; Desmeules F; Perreault K; Campeau-Lecours A; Best K; Beaulieu-Bonneau S; Paquette JS; Deslauriers S; Daigle N; Drouin G; Tittley J; Gagnon MA; Salmam I; Brouillard SM; Lepage K; Roy JS
    BMJ Open; 2023 Mar; 13(3):e064054. PubMed ID: 36921943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale, Design, and Characteristics of the VALIANT (COVID-19 in Older Adults: A Longitudinal Assessment) Cohort.
    Cohen AB; McAvay GJ; Geda M; Chattopadhyay S; Lee S; Acampora D; Araujo K; Charpentier P; Gill TM; Hajduk AM; Ferrante LE
    J Am Geriatr Soc; 2023 Mar; 71(3):832-844. PubMed ID: 36544250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.